These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 25578497)

  • 1. Extracellular cytochrome c as a biomarker for monitoring therapeutic efficacy and prognosis of non-small cell lung cancer patients.
    Javid J; Mir R; Julka PK; Ray PC; Saxena A
    Tumour Biol; 2015 Jun; 36(6):4253-60. PubMed ID: 25578497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of leptin and proinflammatory cytokines in advanced-stage non-small cell lung cancer.
    Tas F; Duranyildiz D; Argon A; Oğuz H; Camlica H; Yasasever V; Topuz E
    Med Oncol; 2005; 22(4):353-8. PubMed ID: 16260852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum cytochrome c indicates in vivo apoptosis and can serve as a prognostic marker during cancer therapy.
    Barczyk K; Kreuter M; Pryjma J; Booy EP; Maddika S; Ghavami S; Berdel WE; Roth J; Los M
    Int J Cancer; 2005 Aug; 116(2):167-73. PubMed ID: 15800951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum APE1 as a predictive marker for platinum-based chemotherapy of non-small cell lung cancer patients.
    Zhang S; He L; Dai N; Guan W; Shan J; Yang X; Zhong Z; Qing Y; Jin F; Chen C; Yang Y; Wang H; Baugh L; Tell G; Wilson DM; Li M; Wang D
    Oncotarget; 2016 Nov; 7(47):77482-77494. PubMed ID: 27813497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of serum Bcl-2 levels in advanced lung cancer patients.
    Tas F; Duranyildiz D; Oguz H; Camlica H; Oral EN; Yasasever V; Topuz E
    Med Oncol; 2005; 22(2):139-43. PubMed ID: 15965276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive and prognostic value of serum periostin in advanced non-small cell lung cancer patients receiving chemotherapy.
    Zhang Y; Yuan D; Yao Y; Sun W; Shi Y; Su X
    Tumour Biol; 2017 May; 39(5):1010428317698367. PubMed ID: 28459197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum vascular endothelial growth factor (VEGF) and bcl-2 levels in advanced stage non-small cell lung cancer.
    Tas F; Duranyildiz D; Oguz H; Camlica H; Yasasever V; Topuz E
    Cancer Invest; 2006 Oct; 24(6):576-80. PubMed ID: 16982461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment Pokemon Level as a Predictor of Response to Cisplatin and Paclitaxel in Patients with Unresectable Non-Small Cell Lung Cancer.
    Zhang QL; Xing XZ; Li FY; Xing YJ; Li J
    Oncol Res Treat; 2015; 38(10):496-502. PubMed ID: 26451776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients.
    Köhler J; Schuler M; Gauler TC; Nöpel-Dünnebacke S; Ahrens M; Hoffmann AC; Kasper S; Nensa F; Gomez B; Hahnemann M; Breitenbuecher F; Cheufou D; Özkan F; Darwiche K; Hoiczyk M; Reis H; Welter S; Eberhardt WE; Eisenacher M; Teschler H; Stamatis G; Schmiegel W; Hahn SA; Baraniskin A
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):795-805. PubMed ID: 26687686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of plasma netrin-1 in non-small cell lung cancer patients as diagnostic and prognostic biomarker.
    Yıldırım ME; Kefeli U; Aydın D; Sener N; Gümüş M
    Tumour Biol; 2016 Sep; 37(9):11903-11907. PubMed ID: 27067437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of apoptosis biomarkers, survivin and TNF-alpha in nonsmall cell lung cancer.
    Derin D; Soydinç HO; Guney N; Tas F; Camlica H; Duranyildiz D; Yasasever V; Topuz E
    Lung Cancer; 2008 Feb; 59(2):240-5. PubMed ID: 17875341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-mobility group nucleosome-binding protein 1 is a novel clinical biomarker in non-small cell lung cancer.
    Wei F; Yang F; Jiang X; Yu W; Ren X
    Tumour Biol; 2015 Dec; 36(12):9405-10. PubMed ID: 26113410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and prognostic importance of XIAP and USP8 in advanced stages of non-small cell lung cancer.
    Baykara M; Yaman M; Buyukberber S; Tufan G; Demirci U; Benekli M; Coskun U; Ozet A; Umit Bagriacik E
    J BUON; 2013; 18(4):921-7. PubMed ID: 24344018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy.
    Chang CH; Hsiao CF; Yeh YM; Chang GC; Tsai YH; Chen YM; Huang MS; Chen HL; Li YJ; Yang PC; Chen CJ; Hsiung CA; Su WC
    Int J Cancer; 2013 May; 132(9):1977-85. PubMed ID: 23034889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers.
    Li BT; Lou E; Hsu M; Yu HA; Naidoo J; Zauderer MG; Sima C; Johnson ML; Daras M; DeAngelis LM; Fleisher M; Kris MG; Azzoli CG
    PLoS One; 2016; 11(1):e0146063. PubMed ID: 26730601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M30/M65 ratio predicts the outcome of paclitaxel chemotherapy for NSCLC.
    Chu T; Jiang L; Ying W; Han B
    Clin Transl Oncol; 2017 Mar; 19(3):326-331. PubMed ID: 27468866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma.
    Ardizzoni A; Cafferata MA; Paganuzzi M; Filiberti R; Marroni P; Neri M; Fontana V; Nicoló G; Perdelli L; Stampino CG; Rosso R; Puntoni R
    Cancer; 2001 Oct; 92(7):1896-904. PubMed ID: 11745263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent low-dose cisplatin and thoracic radiotherapy in patients with inoperable stage III non-small cell lung cancer: a phase II trial with special reference to the hemoglobin level as prognostic parameter.
    Pradier O; Lederer K; Hille A; Weiss E; Christiansen H; Schmidberger H; Hess CF
    J Cancer Res Clin Oncol; 2005 Apr; 131(4):261-9. PubMed ID: 15616830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between Glasgow Prognostic Score and serum tumor markers in patients with advanced non-small cell lung cancer.
    Jiang AG; Chen HL; Lu HY
    BMC Cancer; 2015 May; 15():386. PubMed ID: 25956656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
    Fan J; Yu H; Lv Y; Yin L
    Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.